Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $10.9 million.

  • Ocular Therapeutix's Prepaid Assets fell 1933.57% to $10.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.9 million, marking a year-over-year decrease of 1933.57%. This contributed to the annual value of $10.9 million for FY2025, which is 1933.57% down from last year.
  • Ocular Therapeutix's Prepaid Assets amounted to $10.9 million in Q4 2025, which was down 1933.57% from $8.0 million recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Prepaid Assets peaked at $13.5 million during Q4 2024, and registered a low of $3.3 million during Q3 2022.
  • In the last 5 years, Ocular Therapeutix's Prepaid Assets had a median value of $4.8 million in 2021 and averaged $6.6 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 17048.54% in 2024, then plummeted by 3953.31% in 2025.
  • Ocular Therapeutix's Prepaid Assets (Quarter) stood at $4.8 million in 2021, then fell by 15.22% to $4.0 million in 2022, then soared by 93.5% to $7.8 million in 2023, then surged by 72.66% to $13.5 million in 2024, then fell by 19.34% to $10.9 million in 2025.
  • Its last three reported values are $10.9 million in Q4 2025, $8.0 million for Q3 2025, and $8.8 million during Q2 2025.